2022-04062. Bulk Manufacturer of Controlled Substances Application: S&B Pharma LLC  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    Start Printed Page 10820

    ACTION:

    Notice of application.

    SUMMARY:

    S&B Pharma LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2022. Such persons may also file a written request for a hearing on the application on or before April 26, 2022.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on December 24, 2021, S&B Pharma LLC, 405 South Motor Avenue, Azusa, California 91702, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Gamma Hydroxybutyric Acid2010I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    Amphetamine1100II
    Methamphetamine1105II
    Lisdexamfetamine1205II
    Methylphenidate1724II
    Pentobarbital2270II
    4-Anilino-N-Phenethyl-4-Piperidine (ANPP)8333II
    Tapentadol9780II
    Fentanyl9801II

    The company plans to bulk manufacture the listed controlled substances for the internal use intermediates for formulation and analytical development purposes or for sale to its customers. In reference to dug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Matthew J. Strait,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2022-04062 Filed 2-24-22; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
02/25/2022
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2022-04062
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2022. Such persons may also file a written request for a hearing on the application on or before April 26, 2022.
Pages:
10819-10820 (2 pages)
Docket Numbers:
Docket No. DEA-966
PDF File:
2022-04062.pdf